Cluster-related physiopathogenic hypothesis as standing points for treatment recommendations

Cluster (C)Physiopathogenic hypothesisSimilar EEG/ERP findingsRecommended treatment
1DA hypoactivity in DLPCNeurodegenerative and developmental disordersMPH
2Perisylvian network hyperexcitabilitySpectrum of perisylvian network epilepsiesCBZ
3Excite-inhibit imbalance, thalamocorticalAtypical, phantom absencesVAL
4Misallocation of attentional resourcesSchizophrenia spectrum, other psychosesRSP
5Vascular-metabolic decouplingMigraineVAL, TPM
6Cortical hyperexcitabilityOther mental disordersDirected psychotherapy

First two columns, cluster number and most loaded variables for cluster’s membership (from Table 2). Third column a brief description of the physiopathogenic hypothesis related to the cluster and supporting references. Fourth and fifth columns, other disorders with similar EEG/ERP findings. Last column, recommended treatment for each cluster, based on practice guidelines for the disorders hypothetically sharing some physiopathogenic mechanisms. DA: dopamine; EEG/ERP: electroencephalogram/event-related brain potential; MPH: methylphenidate; CBZ: carbamazepine; VAL: valproic acid; RSP: risperidone; TPM: topiramate